StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
44
This year
2
Publishing Date
2024 - 02 - 08
1
2024 - 01 - 04
1
2023 - 07 - 19
1
2023 - 06 - 22
1
2023 - 05 - 09
1
2023 - 05 - 03
1
2023 - 02 - 09
1
2022 - 12 - 09
2
2022 - 12 - 08
1
2022 - 10 - 06
1
2022 - 09 - 22
1
2022 - 08 - 30
1
2022 - 08 - 22
1
2022 - 07 - 06
1
2022 - 06 - 24
1
2022 - 04 - 29
1
2022 - 04 - 21
1
2022 - 04 - 20
1
2022 - 04 - 19
1
2022 - 02 - 24
1
2022 - 02 - 23
1
2022 - 02 - 10
1
2022 - 01 - 19
1
2021 - 12 - 20
1
2021 - 11 - 29
1
2021 - 11 - 19
1
2021 - 11 - 03
1
2021 - 10 - 29
1
2021 - 10 - 25
1
2021 - 10 - 21
1
2021 - 10 - 18
1
2021 - 10 - 13
1
2021 - 09 - 20
2
2021 - 08 - 05
1
2021 - 06 - 28
1
2021 - 06 - 25
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 10
1
2021 - 06 - 04
1
2021 - 04 - 15
1
2021 - 03 - 26
1
Sector
Distribution services
1
Finance
1
Health technology
44
Manufacturing
2
Process industries
1
Tags
Acquisition
1
Acute myeloid leukemia
2
Alliances
3
Announces collaboration
1
Antibody
1
Antiviral
1
Approval
1
Authorization
1
Bioforest
1
Biomidwest
1
Bioscience
2
Biotech
1
Biotech-bay
6
Biotech-beach
3
Biotechnology
2
Breast
1
Breast cancer
1
Cancer
5
Car-t
1
Chmp
1
Chronic hepatitis b
1
Clinical trials
1
Collaboration
3
Conference
1
Covid
1
Covid-19
1
Day
1
Disease
3
Drug
3
Earnings
1
Events
3
Expected
1
Fda
1
Fda-approvals
2
Financial results
2
Food
1
Genetic
1
Genetown
2
Global
2
Grant
2
Granted
2
Health
1
Hepatitis
3
Hiv
5
Impact
1
Infections
1
Infectious disease
1
Leukemia
3
N/a
7
People
2
Pharma
2
Phase 2
2
Pipeline
2
Research
11
Results
3
T-cell
4
Therapeutics
6
Therapy
5
Treatment
6
Trial
7
Entities
Aadi biosciences inc
2
Alnylam pharmaceuticals, inc.
1
American international group, inc.
1
Aptorum group limited
1
Assembly biosciences, inc.
3
Biontech se
1
Bristol-myers squibb company
1
Durect corporation
1
Exelixis, inc.
1
Fsd pharma inc.
1
G1 therapeutics, inc.
1
Gilead sciences, inc.
44
Halozyme therapeutics, inc.
1
Hookipa pharma inc.
1
Humanigen, inc.
1
Illumina, inc.
1
Immunogen, inc.
2
Innate pharma sa
1
Johnson & johnson
3
Jounce therapeutics, inc.
5
Kronos bio, inc.
1
Morphosys ag
1
Myriad genetics, inc.
1
Pds biotechnology corporation
1
Pfizer, inc.
2
Replimune group, inc.
1
Sanofi
2
Seagen inc.
1
Sensient technologies corporation
1
Stryker corporation
1
Trinity biotech plc
1
Vir biotechnology, inc.
1
Xeris pharmaceuticals, inc.
1
Zai lab limited
1
Symbols
AAPL
60
ABB
42
ABBV
59
ABT
60
ALB
37
ALNY
41
ARVL
218
BHC
37
BKI
129
BLDP
41
BLK
37
BMO
44
BMRN
39
BMY
67
CCLD
41
CNDT
79
CSCO
51
CYBN
49
DCT
52
ERIC
110
EXPR
37
EXTR
67
F
43
FAT
37
FCN
39
FNCTF
463
GE
41
GILD
44
HON
47
IBM
41
INTC
66
IT
55
JAGX
78
JNJ
267
LLY
100
LPLA
95
LTUM
58
MMM
43
MRNA
51
MS
266
MSFT
63
NVO
37
OMQS
48
ORCL
66
PFE
45
PPRUF
62
PPRUY
62
SAP
53
SAPGF
46
SNY
268
SNYNF
218
STIM
39
STM
40
STMEF
40
TMO
71
TRU
50
TWST
51
VZ
120
WEX
64
XYF
72
Exchanges
Nasdaq
44
Nyse
6
Crawled Date
2024 - 02 - 08
1
2024 - 01 - 04
1
2023 - 07 - 19
1
2023 - 06 - 22
1
2023 - 05 - 09
1
2023 - 05 - 03
1
2023 - 02 - 09
1
2022 - 12 - 09
2
2022 - 12 - 08
1
2022 - 10 - 06
1
2022 - 09 - 22
1
2022 - 08 - 30
1
2022 - 08 - 22
1
2022 - 07 - 06
1
2022 - 06 - 24
1
2022 - 04 - 29
1
2022 - 04 - 21
1
2022 - 04 - 20
1
2022 - 04 - 19
1
2022 - 02 - 24
1
2022 - 02 - 23
1
2022 - 02 - 10
1
2022 - 01 - 19
1
2021 - 12 - 20
1
2021 - 11 - 29
1
2021 - 11 - 19
1
2021 - 11 - 03
1
2021 - 10 - 29
1
2021 - 10 - 25
1
2021 - 10 - 21
1
2021 - 10 - 18
1
2021 - 10 - 13
1
2021 - 09 - 20
2
2021 - 08 - 05
1
2021 - 06 - 28
1
2021 - 06 - 25
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 10
1
2021 - 06 - 04
1
2021 - 04 - 15
1
2021 - 03 - 26
1
Crawled Time
00:00
19
00:20
2
01:00
17
02:00
2
03:00
3
04:00
3
04:20
1
06:00
5
07:00
7
08:00
6
09:00
7
09:52
1
10:00
7
10:51
1
11:00
33
11:33
3
12:00
41
12:03
1
12:06
1
12:15
12
12:20
6
12:30
1
12:34
1
13:00
44
13:01
1
13:07
1
13:15
5
13:17
1
13:20
19
13:27
1
13:30
3
13:52
1
14:00
39
14:01
1
14:03
2
14:15
3
14:20
6
14:30
10
15:00
22
15:15
2
15:17
1
15:20
3
15:30
4
15:49
1
15:56
1
15:59
1
16:00
14
16:20
2
17:00
17
17:43
1
18:00
12
18:11
1
18:32
1
19:00
11
19:47
1
20:00
24
21:00
17
21:03
1
22:00
27
23:00
19
Source
www.biospace.com
37
www.globenewswire.com
6
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
GILD
crawled time :
13:00
save search
Assembly Biosciences Announces Effective Date of Reverse Stock Split
Published:
2024-02-08
(Crawled : 13:00)
- globenewswire.com
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-10.29%
|
O:
-0.03%
H:
0.26%
C:
-0.81%
ASMB
|
$13.64
2.33%
2.27%
11K
|
Health Technology
|
1241.27%
|
O:
0.02%
H:
3.0%
C:
-2.49%
Assembly Biosciences Provides Anticipated Development Milestones for 2024
Published:
2024-01-04
(Crawled : 13:00)
- globenewswire.com
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-20.03%
|
O:
0.37%
H:
1.38%
C:
0.82%
ASMB
|
$13.64
2.33%
2.27%
11K
|
Health Technology
|
1552.29%
|
O:
1.84%
H:
0.73%
C:
-2.44%
Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global Collaboration on Health Equity Efforts at IAS 2023
Published:
2023-07-19
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.65%
|
O:
-0.15%
H:
1.92%
C:
1.1%
health
pipeline
global
collaboration
hiv
impact
Kite Announces Completion of Marketing Authorization Transfer for Yescarta® CAR T-cell Therapy in Japan
Published:
2023-06-22
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-13.98%
|
O:
0.18%
H:
0.57%
C:
0.46%
yescarta
japan
transfer
t-cell
authorization
therapy
Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera
Published:
2023-05-09
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-15.05%
|
O:
-0.36%
H:
1.23%
C:
0.63%
pipeline
acquisition
Gilead Remains Steadfast in Support for Hepatitis C Elimination Efforts
Published:
2023-05-03
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-17.01%
|
O:
0.06%
H:
0.51%
C:
-1.29%
hepatitis
Kite’s Tecartus® CAR T-Cell Therapy Demonstrates Overall Survival Benefit in Three-Year Follow-up of Pivotal ZUMA-3 Trial in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Published:
2023-02-09
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-22.07%
|
O:
0.19%
H:
0.9%
C:
-0.35%
tecartus
t-cell
leukemia
trial
therapy
ImmunoGen Announces Clinical Collaboration with Gilead to Evaluate Pivekimab Sunirine in Combination with Magrolimab in Relapsed/Refractory Acute Myeloid Leukemia
Published:
2022-12-09
(Crawled : 13:00)
- biospace.com/
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
501.93%
|
O:
-0.19%
H:
0.77%
C:
-0.77%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-25.38%
|
O:
-0.23%
H:
0.0%
C:
-1.45%
collaboration
leukemia
acute myeloid leukemia
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model Myriad Genetics, Inc., a leader in genetic testing and preci...
Published:
2022-12-09
(Crawled : 13:00)
- biospace.com/
SXT
|
$69.14
1.33%
0.0%
190K
|
Distribution Services
|
-6.31%
|
O:
-0.42%
H:
0.97%
C:
-0.33%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-49.79%
|
O:
-0.06%
H:
2.11%
C:
-0.06%
TRIB
|
$1.81
-3.72%
-3.87%
5.7K
|
Health Technology
|
41.41%
|
O:
-1.56%
H:
1.58%
C:
-1.75%
REPL
|
$6.47
-7.17%
-7.73%
870K
|
Health Technology
|
-73.19%
|
O:
-0.25%
H:
5.25%
C:
4.17%
MYGN
F
|
$18.515
0.03%
0.03%
490K
|
Health Technology
|
-5.08%
|
O:
-0.67%
H:
1.39%
C:
-2.69%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
501.93%
|
O:
-0.19%
H:
0.77%
C:
-0.77%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-25.38%
|
O:
-0.23%
H:
0.0%
C:
-1.45%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-49.47%
|
O:
-0.05%
H:
0.75%
C:
-0.83%
APM
|
$5.9
9.87%
8.98%
37K
|
Health Technology
|
12.75%
|
O:
-16.14%
H:
19.24%
C:
14.67%
risk
breast
genetic
cancer
study
Jounce Therapeutics Presents INNATE Phase 1 and SELECT Clinical Trial data at the European Society of Medical Oncology Immuno-Oncology (ESMO - IO) Annual Congress
Published:
2022-12-08
(Crawled : 13:00)
- globenewswire.com
JNCE
|
$1.88
-2.59%
-1.85%
0
|
Health Technology
|
146.8%
|
O:
1.82%
H:
1.52%
C:
-7.91%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-23.95%
|
O:
0.09%
H:
1.98%
C:
1.82%
medical
trial
therapeutics
phase 1
Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027
Published:
2022-10-06
(Crawled : 13:00)
- prnewswire.com
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
|
-62.04%
|
O:
0.35%
H:
1.48%
C:
-4.65%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
67.12%
|
O:
0.04%
H:
0.67%
C:
-0.47%
PDSB
|
$2.64
-8.97%
-9.85%
880K
|
Health Technology
|
-26.8%
|
O:
-0.55%
H:
6.11%
C:
-0.56%
ILMN
|
$117.43
0.63%
0.63%
1.4M
|
Health Technology
|
-46.26%
|
O:
-0.88%
H:
1.39%
C:
-1.79%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
2.0%
|
O:
-0.86%
H:
0.72%
C:
0.09%
treatment
global
expected
cancer
market
Gilead Joins First-of-its-Kind Public-Private Initiative to Improve Management of Viral Hepatitis in Vietnam and the Philippines
Published:
2022-09-22
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
5.13%
|
O:
-0.24%
H:
1.52%
C:
0.66%
hepatitis
management
Jounce Therapeutics Reports Results from Phase 2 Randomized SELECT Trial Testing 2 Different Doses of Vopratelimab in TISvopra Biomarker-Selected Patients
Published:
2022-08-30
(Crawled : 13:00)
- biospace.com/
JNCE
|
$1.88
-2.59%
-1.85%
0
|
Health Technology
|
-53.47%
|
O:
-20.58%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
6.9%
|
O:
0.1%
H:
0.29%
C:
-0.02%
trial
therapeutics
results
phase 2
Kronos Bio Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Lanraplenib in Combination with Gilteritinib in Acute Myeloid Leukemia
Published:
2022-08-22
(Crawled : 13:00)
- biospace.com/
KRON
|
$0.99
-3.88%
-4.04%
120K
|
Health Technology
|
-76.29%
|
O:
-1.64%
H:
1.19%
C:
-4.53%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
2.17%
|
O:
-0.2%
H:
0.06%
C:
-1.3%
leukemia
trial
acute myeloid leukemia
phase 2b
Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by C-Reactive Protein
Published:
2022-07-06
(Crawled : 13:00)
- biospace.com/
HGEN
|
$0.0361
-61.5%
120M
|
Health Technology
|
-98.01%
|
O:
0.0%
H:
27.62%
C:
14.36%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
7.37%
|
O:
0.72%
H:
0.41%
C:
0.18%
covid-19
treatment
lenzilumab
publication
Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV
Published:
2022-06-24
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
7.99%
|
O:
1.52%
H:
0.0%
C:
0.0%
chmp
hiv
positive
drug
Allogene, Progenity, Adaptive Phage Tout New Top Executives
Published:
2022-04-29
(Crawled : 13:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-11.29%
|
O:
0.48%
H:
0.24%
C:
0.24%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-18.82%
|
O:
-0.13%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.41%
|
O:
1.93%
H:
0.0%
C:
0.0%
HALO
M
|
$38.64
2.2%
2.15%
1.3M
|
Health Technology
|
-8.61%
|
O:
-2.18%
H:
1.04%
C:
-3.53%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
9.28%
|
O:
0.77%
H:
0.81%
C:
-3.61%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
-0.79%
|
O:
0.22%
H:
1.67%
C:
-1.8%
DRRX
|
$0.9019
-0.89%
-0.9%
110K
|
Health Technology
|
83.54%
|
O:
-0.36%
H:
1.84%
C:
-4.72%
FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board
Published:
2022-04-21
(Crawled : 13:00)
- biospace.com/
SYK
|
$325.43
-0.62%
0.0%
1.8M
|
Health Technology
|
19.18%
|
O:
1.27%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-48.0%
|
O:
-0.16%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-35.65%
|
O:
1.59%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
5.83%
|
O:
0.68%
H:
0.0%
C:
0.0%
HUGE
|
$0.6167
1.22%
29K
|
Process Industries
|
-42.92%
|
O:
0.0%
H:
0.0%
C:
0.0%
pharma
Jounce Therapeutics to Participate in Raymond James LILRB/ILT Symposium: Deep Dive into “Myeloid Checkpoint” Therapeutics in Cancer
Published:
2022-04-20
(Crawled : 13:00)
- biospace.com/
JNCE
|
$1.88
-2.59%
-1.85%
0
|
Health Technology
|
-71.81%
|
O:
1.85%
H:
4.2%
C:
2.17%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
8.38%
|
O:
2.4%
H:
0.0%
C:
0.0%
therapeutics
cancer
Kite Receives U.S. FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland
Published:
2022-04-19
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
8.18%
|
O:
-0.18%
H:
0.0%
C:
0.0%
fda
t-cell
approval
therapy
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.